51 related articles for article (PubMed ID: 28456516)
1. Discovery of novel quinoline-based analogues of combretastatin A-4 as tubulin polymerisation inhibitors with apoptosis inducing activity and potent anticancer effect.
Ibrahim TS; Hawwas MM; Malebari AM; Taher ES; Omar AM; Neamatallah T; Abdel-Samii ZK; Safo MK; Elshaier YAMM
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):802-818. PubMed ID: 33730937
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis of combretastatin A-4 piperazine derivatives as potential antitumor agents by inhibiting tubulin polymerization and inducing autophagy in HCT116 cells.
Zhang H; Li M; Zhou X; Tang L; Chen G; Zhang Y
Eur J Med Chem; 2024 Jun; 272():116497. PubMed ID: 38759453
[TBL] [Abstract][Full Text] [Related]
3. Microtubule Destabilizing Sulfonamides as an Alternative to Taxane-Based Chemotherapy.
González M; Ovejero-Sánchez M; Vicente-Blázquez A; Álvarez R; Herrero AB; Medarde M; González-Sarmiento R; Peláez R
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33673002
[TBL] [Abstract][Full Text] [Related]
4. Lead optimization of novel quinolone chalcone compounds by a structure-activity relationship (SAR) study to increase efficacy and metabolic stability.
Knockleby J; Djigo AD; Lindamulage IK; Karthikeyan C; Trivedi P; Lee H
Sci Rep; 2021 Nov; 11(1):21576. PubMed ID: 34732782
[TBL] [Abstract][Full Text] [Related]
5. Combretastatins: An Overview of Structure, Probable Mechanisms of Action and Potential Applications.
Karatoprak GŞ; Küpeli Akkol E; Genç Y; Bardakci H; Yücel Ç; Sobarzo-Sánchez E
Molecules; 2020 May; 25(11):. PubMed ID: 32486408
[TBL] [Abstract][Full Text] [Related]
6. Efficient assembly and anti-tumor evaluation of novel polycyclic [1,2-a]-fused indoles.
Guo H; Tian Y; Wu X; Tu L; Liu J; Zheng Y; Huang R
Bioorg Chem; 2024 May; 146():107289. PubMed ID: 38493636
[TBL] [Abstract][Full Text] [Related]
7. Design, concise synthesis and evaluation of novel amide-based combretastatin A-4 analogues as potent tubulin inhibitors.
Ma Y; Wang T; Cheng L; Ma X; Li R; Zhang M; Chen J; Zhao P
Bioorg Med Chem Lett; 2024 May; 108():129816. PubMed ID: 38806101
[TBL] [Abstract][Full Text] [Related]
8. Potent Quinoline-Containing Combretastatin A-4 Analogues: Design, Synthesis, Antiproliferative, and Anti-Tubulin Activity.
Ibrahim TS; Hawwas MM; Malebari AM; Taher ES; Omar AM; O'Boyle NM; McLoughlin E; Abdel-Samii ZK; Elshaier YAMM
Pharmaceuticals (Basel); 2020 Nov; 13(11):. PubMed ID: 33203182
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationship study of new carbazole sulfonamide derivatives as anticancer agents with dual-target mechanism.
Liu Y; Zhang J; Tian J; Wang C; Wang T; Gong J; Hu L
Eur J Med Chem; 2024 May; 273():116509. PubMed ID: 38781920
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of combretastatin A-4 sulfamate derivatives as potential anti-cancer agents.
Huang L; Huang J; Nie H; Li Y; Song L; Wu F
RSC Med Chem; 2021 Aug; 12(8):1374-1380. PubMed ID: 34458740
[TBL] [Abstract][Full Text] [Related]
11. Discovery of novel octahydroquinazoline scaffolds endowed with dual inhibition of tubulin polymerization/Eg5 against HCC: Apoptotic and radio-chemotherapeutic studies.
Abdelhameid MK; Taher ES; Hara MA; Ramadan M; Mohamed KO
Bioorg Chem; 2024 May; 148():107449. PubMed ID: 38759356
[TBL] [Abstract][Full Text] [Related]
12. A Novel 2-Methoxyestradiol Derivative: Disrupting Mitosis Inhibiting Cell Motility and Inducing Apoptosis in HeLa Cells In Vitro.
Njangiru IK; Bózsity-Faragó N; Resch VE; Paragi G; Frank É; Balogh GT; Zupkó I; Minorics R
Pharmaceutics; 2024 May; 16(5):. PubMed ID: 38794284
[TBL] [Abstract][Full Text] [Related]
13. Indole derivatives as tubulin polymerization inhibitors for the development of promising anticancer agents.
Hong Y; Zhu YY; He Q; Gu SX
Bioorg Med Chem; 2022 Feb; 55():116597. PubMed ID: 34995858
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of 5H-[1,2,4]triazino[5,6-b]indole derivatives bearing a pyridinocycloalkyl moiety as iron chelators.
Li H; Gao Y; Ni X; Xiong Y; Zhang P; Liu H; Wu X; Tong D; Wang C; Ma J
Mol Divers; 2024 May; ():. PubMed ID: 38733433
[TBL] [Abstract][Full Text] [Related]
15. Angiogenesis and anti-leukaemia activity of novel indole derivatives as potent colchicine binding site inhibitors.
Yao Y; Huang T; Wang Y; Wang L; Feng S; Cheng W; Yang L; Duan Y
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):652-665. PubMed ID: 35109719
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel 1-indolyl acetate-5-nitroimidazole derivatives of combretastatin A-4 as potential tubulin polymerization inhibitors.
Yao YF; Wang ZC; Wu SY; Li QF; Yu C; Liang XY; Lv PC; Duan YT; Zhu HL
Biochem Pharmacol; 2017 Aug; 137():10-28. PubMed ID: 28456516
[TBL] [Abstract][Full Text] [Related]
17. A novel synthetic compound exerts effective anti-tumour activity in vivo via the inhibition of tubulin polymerisation in A549 cells.
Yan J; Pang Y; Sheng J; Wang Y; Chen J; Hu J; Huang L; Li X
Biochem Pharmacol; 2015 Sep; 97(1):51-61. PubMed ID: 26212540
[TBL] [Abstract][Full Text] [Related]
18. Design, Synthesis and Antitumor Activity of Novel link-bridge and B-Ring Modified Combretastatin A-4 (CA-4) Analogues as Potent Antitubulin Agents.
Duan YT; Man RJ; Tang DJ; Yao YF; Tao XX; Yu C; Liang XY; Makawana JA; Zou MJ; Wang ZC; Zhu HL
Sci Rep; 2016 May; 6():25387. PubMed ID: 27138035
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and biological evaluation of novel combretastatin A-4 thio derivatives as microtubule targeting agents.
Stefański T; Mikstacka R; Kurczab R; Dutkiewicz Z; Kucińska M; Murias M; Zielińska-Przyjemska M; Cichocki M; Teubert A; Kaczmarek M; Hogendorf A; Sobiak S
Eur J Med Chem; 2018 Jan; 144():797-816. PubMed ID: 29291446
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
